Athira Pharma Ownership 2024 | Who Owns Athira Pharma Now?
Institutional Ownership
57.91%
Insider Ownership
2.17%
Retail Ownership
39.92%
Institutional Holders
69.00
Athira Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 14.10% | 0.34% | 5,402,964 | - | - | 14,317,855 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 8.23% | 0.11% | 3,153,807 | - | - | 8,357,589 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.26% | 0.00% | 1,634,433 | - | - | 4,331,248 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 3.90% | 0.27% | 1,492,792 | - | - | 3,955,899 | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | 3.90% | 2.57% | 1,492,792 | - | - | 3,955,899 | Jun 30, 2024 |
| WASATCH ADVISORS LP | 3.38% | 0.02% | 1,296,128 | 1,296,128 | 100.00% | 3,434,739 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.75% | 0.28% | 1,052,715 | 200,000 | 23.45% | 2,789,695 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 2.35% | 1.70% | 900,000 | - | - | 2,385,000 | Jun 30, 2024 |
| BLACKROCK INC. | 1.76% | - | 676,244 | 8,966 | 1.34% | 1,792,046 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.44% | 0.00% | 550,353 | 111,759 | 25.48% | 1,458,435 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.32% | 0.01% | 506,815 | 9,340 | 1.88% | 1,343,060 | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | 1.28% | 0.01% | 492,226 | - | - | 1,304,399 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.83% | 0.00% | 318,090 | -231,848 | -42.16% | 842,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.80% | 0.00% | 307,185 | 6,948 | 2.31% | 814,258 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.79% | 0.00% | 302,133 | -123,472 | -29.01% | 800,652 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.71% | 0.00% | 271,488 | 9,164 | 3.49% | 719,443 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.60% | 0.00% | 228,655 | 253 | 0.11% | 605,935 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.47% | 0.51% | 180,000 | - | - | 477,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.39% | 0.01% | 151,073 | -24,900 | -14.15% | 400,343 | Jun 30, 2024 |
| LAIRD NORTON TRUST COMPANY, LLC | 0.38% | 0.06% | 147,309 | - | - | 390,369 | Jun 30, 2024 |
Athira Pharma's largest institutional shareholder is PERCEPTIVE ADVISORS LLC, holding 14.10% of the company's total share outstanding, currently valued at $14.32M. The top 10 institutional shareholders own together 46.06% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PROPEL BIO MANAGEMENT, LLC | 3.90% | 2.57% | 1,492,792 | - | - | 3,955,899 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 2.35% | 1.70% | 900,000 | - | - | 2,385,000 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.47% | 0.51% | 180,000 | - | - | 477,000 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 14.10% | 0.34% | 5,402,964 | - | - | 14,317,855 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.75% | 0.28% | 1,052,715 | 200,000 | 23.45% | 2,789,695 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 3.90% | 0.27% | 1,492,792 | - | - | 3,955,899 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 8.23% | 0.11% | 3,153,807 | - | - | 8,357,589 | Jun 30, 2024 |
| FOREFRONT ANALYTICS, LLC | 0.12% | 0.06% | 46,595 | 25,979 | 126.01% | 123,477 | Jun 30, 2024 |
| LAIRD NORTON TRUST COMPANY, LLC | 0.38% | 0.06% | 147,309 | - | - | 390,369 | Jun 30, 2024 |
| INTEGRITY FINANCIAL CORP /WA | 0.09% | 0.05% | 32,786 | - | - | 86,883 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.19% | 0.03% | 74,641 | -748 | -0.99% | 197,799 | Jun 30, 2024 |
| BRISTLECONE ADVISORS, LLC | 0.22% | 0.02% | 85,306 | - | - | 226,061 | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | 0.11% | 0.02% | 40,478 | -1,601 | -3.80% | 107,267 | Jun 30, 2024 |
| WASATCH ADVISORS LP | 3.38% | 0.02% | 1,296,128 | 1,296,128 | 100.00% | 3,434,739 | Jun 30, 2024 |
| SARGENT INVESTMENT GROUP, LLC | 0.05% | 0.01% | 19,516 | -237 | -1.20% | 51,717 | Jun 30, 2024 |
| CLARIUS GROUP, LLC | 0.14% | 0.01% | 53,551 | - | - | 141,910 | Jun 30, 2024 |
| MIRADOR CAPITAL PARTNERS LP | 0.05% | 0.01% | 20,040 | -620 | -3.00% | 53,106 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.39% | 0.01% | 151,073 | -24,900 | -14.15% | 400,343 | Jun 30, 2024 |
| EASTERLY INVESTMENT PARTNERS LLC | 0.09% | 0.01% | 33,500 | - | - | 88,775 | Jun 30, 2024 |
| INVST, LLC | 0.07% | 0.01% | 27,000 | 27,000 | 100.00% | 67,770 | Jun 30, 2024 |
The largest Athira Pharma shareholder by % of total assets is PROPEL BIO MANAGEMENT, LLC. The company owns 1.49M shares of Athira Pharma (ATHA), representing 2.57% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 3.38% | 0.02% | 1,296,128 | 1,296,128 | 100.00% | 3,434,739 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 2.75% | 0.28% | 1,052,715 | 200,000 | 23.45% | 2,789,695 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.44% | 0.00% | 550,353 | 111,759 | 25.48% | 1,458,435 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.14% | - | 55,409 | 47,358 | 588.23% | 147,000 | Jun 30, 2024 |
| INVST, LLC | 0.07% | 0.01% | 27,000 | 27,000 | 100.00% | 67,770 | Jun 30, 2024 |
| FOREFRONT ANALYTICS, LLC | 0.12% | 0.06% | 46,595 | 25,979 | 126.01% | 123,477 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.01% | 22,695 | 22,695 | 100.00% | 60,142 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.32% | 0.01% | 506,815 | 9,340 | 1.88% | 1,343,060 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.71% | 0.00% | 271,488 | 9,164 | 3.49% | 719,443 | Jun 30, 2024 |
| BLACKROCK INC. | 1.76% | - | 676,244 | 8,966 | 1.34% | 1,792,046 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.80% | 0.00% | 307,185 | 6,948 | 2.31% | 814,258 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.10% | 0.00% | 38,940 | 3,333 | 9.36% | 103,191 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.04% | 0.00% | 15,273 | 671 | 4.60% | 40,473,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.14% | - | 53,609 | 389 | 0.73% | 142,064,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.60% | 0.00% | 228,655 | 253 | 0.11% | 605,935 | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 932 | - | - | 2,470 | Jun 30, 2024 |
| US BANCORP \DE\ | 0.00% | - | 815 | - | - | 2,160 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.00% | - | 1,532 | - | - | 4,059 | Jun 30, 2024 |
| STATE STREET CORP | 0.28% | - | 107,781 | - | - | 285,620,000 | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | 0.03% | 0.00% | 12,468 | - | - | 33,000 | Jun 30, 2024 |
As of Jun 30 2024, Athira Pharma's largest institutional buyer is WASATCH ADVISORS LP. The company purchased 1.30M stocks of ATHA, valued at $3.43M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | 0.83% | 0.00% | 318,090 | -231,848 | -42.16% | 842,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.10% | 0.01% | 39,324 | -136,906 | -77.69% | 104,000 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.08% | 0.00% | 30,050 | -133,539 | -81.63% | 79,633 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.03% | - | 10,547 | -131,114 | -92.55% | 27,950 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.79% | 0.00% | 302,133 | -123,472 | -29.01% | 800,652 | Jun 30, 2024 |
| BAILARD, INC. | - | - | - | -40,473 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.27% | 0.00% | 103,065 | -28,601 | -21.72% | 273,000 | Jun 30, 2024 |
| BLAIR WILLIAM & CO/IL | 0.03% | 0.00% | 10,000 | -26,045 | -72.26% | 26,500 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.39% | 0.01% | 151,073 | -24,900 | -14.15% | 400,343 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -24,200 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -21,278 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.06% | - | 23,200 | -19,299 | -45.41% | 61,480 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -17,749 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.07% | - | 26,789 | -13,262 | -33.11% | 70,991 | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | - | - | - | -11,777 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -10,999 | -100.00% | - | Jun 30, 2024 |
| FRG FAMILY WEALTH ADVISORS LLC | - | - | - | -9,195 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 143 | -7,394 | -98.10% | 379 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.05% | 0.00% | 17,936 | -5,731 | -24.22% | 47,530 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.03% | - | 13,010 | -5,315 | -29.00% | 34,000 | Jun 30, 2024 |
As of Jun 30 2024, Athira Pharma's biggest institutional seller is ACADIAN ASSET MANAGEMENT LLC. The company sold -0.23M shares of ATHA, valued at $842.00K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 3.38% | 0.02% | 1,296,128 | 1,296,128 | 100.00% | 3,434,739 | Jun 30, 2024 |
| INVST, LLC | 0.07% | 0.01% | 27,000 | 27,000 | 100.00% | 67,770 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.01% | 22,695 | 22,695 | 100.00% | 60,142 | Jun 30, 2024 |
Athira Pharma's largest new institutional shareholder by number of shares is WASATCH ADVISORS LP, purchased 1.30M shares, valued at $3.43M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAILARD, INC. | - | - | - | -40,473 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -24,200 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -21,278 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -17,749 | -100.00% | - | Jun 30, 2024 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | - | - | - | -11,777 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -10,999 | -100.00% | - | Jun 30, 2024 |
| FRG FAMILY WEALTH ADVISORS LLC | - | - | - | -9,195 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -4,559 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -520 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -238 | -100.00% | - | Jun 30, 2024 |
| MATHER GROUP, LLC. | - | - | - | -175 | -100.00% | - | Jun 30, 2024 |
| HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC | - | - | - | -150 | -100.00% | - | Jun 30, 2024 |
Athira Pharma's largest sold out institutional shareholder by shares sold is BAILARD, INC., sold -40.47K shares, valued at -, as of undefined.
Athira Pharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Collaborative Investment Series Trust | 0.19% | 29,091 | - | - | Mar 31, 2024 |
| WASATCH FUNDS TRUST | 0.13% | 1,230,973 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.08% | 666,676 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.07% | 175,973 | -36,100 | -17.02% | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 26,677 | - | - | Mar 31, 2024 |
| Simplify Exchange Traded Funds | 0.03% | 1,492,792 | - | - | Mar 28, 2024 |
| ETFis Series Trust I | 0.01% | 13,008 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,925 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 48,613 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.00% | 5,000 | - | - | Mar 28, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 866 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,573,128 | -514,565 | -24.65% | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 37,648 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 274,179 | 15,699 | 6.07% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 5,177 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 25,563 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,529 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 21,370 | -1,473 | -6.45% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 12,560 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 90,416 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 13,857 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 9,760 | -846 | -7.98% | Mar 31, 2024 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 155,670 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 235,358 | -11,534 | -4.67% | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 550 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 927 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 1,770 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 24,400 | 20,090 | 466.13% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 19,201 | 3,932 | 25.75% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 71,910 | -34,110 | -32.17% | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 77,715 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 7,900 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 16,897 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,332 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 313 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 291,543 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,579 | - | - | Feb 29, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 300 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 119,086 | - | - | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 4,386 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 12,514 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,200 | - | - | Mar 28, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 4,800 | 1,100 | 29.73% | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 155 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 431 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 192 | - | - | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 4,311 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 72,090 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 1,496 | - | - | Feb 29, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 73,415 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 20 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,889 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 4,020 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,424 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 13,703 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,072 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,896 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 2,174 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 189 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 8,493 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 20,538 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 69,971 | -2,571 | -3.54% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 4,973 | -890 | -15.18% | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 17,769 | 17,667 | 17320.59% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 130,925 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,618 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 10,768 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 706 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 4,848 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 6,521 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 171 | -38 | -18.18% | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,783 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 4,253 | - | - | Mar 28, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 61 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,621 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,185 | - | - | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 3,838 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 4,800 | - | - | Feb 29, 2024 |
Athira Pharma's largest mutual fund holder by % of total assets is "Collaborative Investment Series Trust", owning 29.09K shares, compromising 0.19% of its total assets.
Athira Pharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 69 | -12.66% |
| 31 Mar, 24 | 79 | 17.91% |
| 31 Dec, 23 | 67 | -8.22% |
| 30 Sep, 23 | 73 | -8.75% |
| 30 Jun, 23 | 80 | -5.88% |
| 31 Mar, 23 | 85 | -12.37% |
| 31 Dec, 22 | 97 | -4.90% |
| 30 Sep, 22 | 102 | -11.30% |
| 30 Jun, 22 | 115 | -10.16% |
| 31 Mar, 22 | 128 | 6.67% |
| 31 Dec, 21 | 120 | 21.21% |
| 30 Sep, 21 | 99 | 4.21% |
| 30 Jun, 21 | 95 | 39.71% |
| 31 Mar, 21 | 68 | -2.86% |
| 31 Dec, 20 | 70 | 29.63% |
| 30 Sep, 20 | 54 | - |
As of 30 Jun 24, 69 institutions are holding Athira Pharma's shares, representing a decrease of -12.66% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 22,193,550 | 2.25% |
| 31 Mar, 24 | 21,705,121 | -0.90% |
| 31 Dec, 23 | 21,901,553 | 2.19% |
| 30 Sep, 23 | 21,432,485 | -2.08% |
| 30 Jun, 23 | 21,887,594 | -8.04% |
| 31 Mar, 23 | 23,800,339 | 0.48% |
| 31 Dec, 22 | 23,687,040 | 6.76% |
| 30 Sep, 22 | 22,188,202 | 0.45% |
| 30 Jun, 22 | 22,089,363 | -16.13% |
| 31 Mar, 22 | 26,338,213 | 0.33% |
| 31 Dec, 21 | 26,250,319 | 5.35% |
| 30 Sep, 21 | 24,916,782 | 0.73% |
| 30 Jun, 21 | 24,737,173 | -6.08% |
| 31 Mar, 21 | 26,338,868 | 22.32% |
| 31 Dec, 20 | 21,532,365 | -0.58% |
| 30 Sep, 20 | 21,658,200 | - |
Athira Pharma (ATHA) has 22.19M shares outstanding as of 30 Jun 24, up 2.25% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 57.91% | 1.79% |
| 31 Mar, 24 | 56.95% | 1.72% |
| 31 Dec, 23 | 57.55% | 1.81% |
| 30 Sep, 23 | 56.40% | 1.69% |
| 30 Jun, 23 | 57.72% | 1.47% |
| 31 Mar, 23 | 62.76% | 1.59% |
| 31 Dec, 22 | 62.77% | 1.82% |
| 30 Sep, 22 | 58.67% | 1.71% |
| 30 Jun, 22 | 58.64% | 1.19% |
| 31 Mar, 22 | 70.06% | 1.39% |
| 31 Dec, 21 | 71.10% | 1.59% |
| 30 Sep, 21 | 66.78% | 1.51% |
| 30 Jun, 21 | 66.47% | 1.23% |
| 31 Mar, 21 | 73.62% | 2.03% |
| 31 Dec, 20 | 60.19% | 1.64% |
| 30 Sep, 20 | 60.54% | - |
As of 30 Jun 24, Athira Pharma is held by 57.91% institutional shareholders, representing a 1.79% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 15 | -58.33% |
| 31 Mar, 24 | 36 | 63.64% |
| 31 Dec, 23 | 22 | 22.22% |
| 30 Sep, 23 | 18 | -40.00% |
| 30 Jun, 23 | 30 | -18.92% |
| 31 Mar, 23 | 37 | -27.45% |
| 31 Dec, 22 | 51 | -3.77% |
| 30 Sep, 22 | 53 | -10.17% |
| 30 Jun, 22 | 59 | 20.41% |
| 31 Mar, 22 | 49 | -12.50% |
| 31 Dec, 21 | 56 | 12.00% |
| 30 Sep, 21 | 50 | -24.24% |
| 30 Jun, 21 | 66 | 78.38% |
| 31 Mar, 21 | 37 | -27.45% |
| 31 Dec, 20 | 51 | -5.56% |
| 30 Sep, 20 | 54 | - |
15 institutional shareholders have increased their position in ATHA stock as of 30 Jun 24 compared to 36 in the previous quarter (a -58.33% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 23 | 27.78% |
| 31 Mar, 24 | 18 | -10.00% |
| 31 Dec, 23 | 20 | -33.33% |
| 30 Sep, 23 | 30 | -11.76% |
| 30 Jun, 23 | 34 | 17.24% |
| 31 Mar, 23 | 29 | 26.09% |
| 31 Dec, 22 | 23 | 35.29% |
| 30 Sep, 22 | 17 | -34.62% |
| 30 Jun, 22 | 26 | -31.58% |
| 31 Mar, 22 | 38 | 15.15% |
| 31 Dec, 21 | 33 | 32.00% |
| 30 Sep, 21 | 25 | 92.31% |
| 30 Jun, 21 | 13 | -13.33% |
| 31 Mar, 21 | 15 | 25.00% |
| 31 Dec, 20 | 12 | - |
| 30 Sep, 20 | - | - |
23 institutional shareholders have reduced their position in ATHA stock as of 30 Jun 24 compared to 18 in the previous quarter (a 27.78% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 69 | -12.66% | 22,193,550 | 2.25% | 57.91% | 1.79% | 15 | -58.33% | 23 | 27.78% |
| 31 Mar, 24 | 79 | 17.91% | 21,705,121 | -0.90% | 56.95% | 1.72% | 36 | 63.64% | 18 | -10.00% |
| 31 Dec, 23 | 67 | -8.22% | 21,901,553 | 2.19% | 57.55% | 1.81% | 22 | 22.22% | 20 | -33.33% |
| 30 Sep, 23 | 73 | -8.75% | 21,432,485 | -2.08% | 56.40% | 1.69% | 18 | -40.00% | 30 | -11.76% |
| 30 Jun, 23 | 80 | -5.88% | 21,887,594 | -8.04% | 57.72% | 1.47% | 30 | -18.92% | 34 | 17.24% |
| 31 Mar, 23 | 85 | -12.37% | 23,800,339 | 0.48% | 62.76% | 1.59% | 37 | -27.45% | 29 | 26.09% |
| 31 Dec, 22 | 97 | -4.90% | 23,687,040 | 6.76% | 62.77% | 1.82% | 51 | -3.77% | 23 | 35.29% |
| 30 Sep, 22 | 102 | -11.30% | 22,188,202 | 0.45% | 58.67% | 1.71% | 53 | -10.17% | 17 | -34.62% |
| 30 Jun, 22 | 115 | -10.16% | 22,089,363 | -16.13% | 58.64% | 1.19% | 59 | 20.41% | 26 | -31.58% |
| 31 Mar, 22 | 128 | 6.67% | 26,338,213 | 0.33% | 70.06% | 1.39% | 49 | -12.50% | 38 | 15.15% |
| 31 Dec, 21 | 120 | 21.21% | 26,250,319 | 5.35% | 71.10% | 1.59% | 56 | 12.00% | 33 | 32.00% |
| 30 Sep, 21 | 99 | 4.21% | 24,916,782 | 0.73% | 66.78% | 1.51% | 50 | -24.24% | 25 | 92.31% |
| 30 Jun, 21 | 95 | 39.71% | 24,737,173 | -6.08% | 66.47% | 1.23% | 66 | 78.38% | 13 | -13.33% |
| 31 Mar, 21 | 68 | -2.86% | 26,338,868 | 22.32% | 73.62% | 2.03% | 37 | -27.45% | 15 | 25.00% |
| 31 Dec, 20 | 70 | 29.63% | 21,532,365 | -0.58% | 60.19% | 1.64% | 51 | -5.56% | 12 | - |
| 30 Sep, 20 | 54 | - | 21,658,200 | - | 60.54% | - | 54 | - | - | - |
Athira Pharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Athira Pharma's stock was made by Gengos Andrew on Feb 16 2024, selling 1,208 shares at $2.91 per share (valued at $3.52K). The last insider buy of ATHA was made by Romano Kelly A on Jun 25 2024, buying 27,400 shares at $2.42 per share (worth $66.18K).
Athira Pharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 10 | - | - |
| Q1 2024 | 11 | 5 | 220.00% |
| Q4 2023 | 4 | - | - |
| Q2 2023 | 22 | 2 | 1100.00% |
| Q1 2023 | 12 | 3 | 400.00% |
| Q4 2022 | 8 | 2 | 400.00% |
| Q2 2022 | 28 | 7 | 400.00% |
| Q1 2022 | 12 | 5 | 240.00% |
| Q4 2021 | 6 | - | - |
| Q3 2021 | 3 | 3 | 100.00% |
| Q2 2021 | 13 | 7 | 185.71% |
| Q1 2021 | 9 | 3 | 300.00% |
| Q4 2020 | 1 | 1 | 100.00% |
| Q3 2020 | 11 | 38 | 28.95% |
10 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Athira Pharma's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 2 | - | - |
| Q1 2024 | - | 5 | - |
| Q4 2023 | 3 | - | - |
| Q2 2023 | 10 | - | - |
| Q1 2023 | 3 | 2 | 150.00% |
| Q4 2022 | 3 | - | - |
| Q2 2022 | 4 | 5 | 80.00% |
| Q1 2022 | 1 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 1 | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 3 | - | - |
As of Q2 2024, Insider owners conducted 2 open market buy trades and 0 open market sell trades of Athira Pharma's stocks.
ATHA Ownership FAQ
Who Owns Athira Pharma?
Athira Pharma is owned by institutional shareholders (57.91%), insiders (2.17%), and public (39.92%). The largest institutional shareholder of Athira Pharma is PERCEPTIVE ADVISORS LLC (14.10% of total shares) and the top mutual fund owner is Collaborative Investment Series Trust (0.19% of total shares).
Who are the major institutional shareholders of Athira Pharma?
Athira Pharma's major institutional shareholders are PERCEPTIVE ADVISORS LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, SIMPLIFY ASSET MANAGEMENT INC., and PROPEL BIO MANAGEMENT, LLC. The top five shareholders own together 34.38% of the company's share outstanding.
How many Athira Pharma shareholders are there?
As of Jun 2024, there are 69 institutional shareholders of Athira Pharma.
What percentage of Athira Pharma is owned by PERCEPTIVE ADVISORS LLC?
PERCEPTIVE ADVISORS LLC owns 5.4M shares of Athira Pharma, representing 14.10% of the company's total shares outstanding, valued at $14.32M (as of Jun 2024).
What percentage of Athira Pharma is owned by BAKER BROS. ADVISORS LP?
As of Jun 2024, BAKER BROS. ADVISORS LP holds 3.15M shares of Athira Pharma (ATHA), compromising 8.23% of the company, valued at $8.36M.
What percentage of Athira Pharma is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Athira Pharma. The company owns 1.63M of the company's shares outstanding (worth $4.33M).